- MicroRNA therapeutics for cardiovascular disease: opportunities and obstaclesvan Rooij Eva; Olson Eric NNature Reviews Drug Discovery, 2012, 11(11): 860-872.
- Targeting NEAT1 in heart diseaseZhang, Mengting; Yang, Jun; Zhang, Jing; Yang, Jian; Liu, Haiyin; Zhai, Yuhong; Zhang, PeiyueInternational Journal of Cardiology, 2022, 348: 22-22.被引 2
- Overlapping Effects of miR-21 Inhibition and Drugs for Idiopathic Pulmonary Fibrosis: Rationale for Repurposing Nintedanib as a Novel Treatment for Ischemia/Reperfusion InjuryAlberto, Aimo; Oriol I., Egea; Michele, Emdin; Antoni, Bayes-GenisJournal of Cardiovascular Pharmacology, 2021, 77(3): 332-333.
期刊论文
Myocarsdial-derived miR-29a-regulated DNMTs: A novel therapeutic target for myocardial fibrosis
2被引14阅读
